27 students from Spain, Peru, Colombia, Costa Rica and the United States have started the Master's Degree in research Biomedicine at the University of Navarra. The program, which celebrates its sixth edition, will have for the first time four specialties: cancer, Neuroscience and Cognition, nutrition and metabolism and translational research (techniques of research).

Of the total number of students, a large number have opted for the specialties of research translational and Neuroscience and Cognition. The latter highlights the"awareness that neurodegenerative diseases are becoming more and more evident, the population is getting older and one of the challenges is to treat Alzheimer's and Parkinson's so that pharmacology can be applied to delay or alleviate these diseases," explained Guillermo Zalba, director of the Program.

The specialization program in cancer highlights the pathophysiological aspects of this disease as well as its research techniques and therapeutic strategies. The specialization program in translational research brings to student training advanced histopathological and imaging techniques or in the development of new generation systems, among others. Finally, the specialization program in nutrition and metabolism is based on early diagnosis and personalized treatment of disorders related to this field.

The Master's Degree in research Biomedical has an interdisciplinary character and it involves the Schools of Sciences, Pharmacy, and Medicine, the research center Applied Medicine, the research center in Nutrition, and the Clínica Universidad de Navarra. "In this way, the student can combine the teaching with the more basic research and the one more applied to the patient".

The postgraduate program takes place over one year and is divided into a theoretical part and another part dedicated to the realization of a work of research, where the student can choose from more than 50 experimental projects. Among the employment opportunities offered by the program are research and industry: laboratories, biotechnology and pharmaceutical companies.

In the short deadline, the Master's Degree will have 80% of the teaching in English to welcome foreign students. "We have incentive programs with scholarships, especially for those with good transcript and curriculum... we want to bring in the brightest," added the director.